Can Fite Biofarma Ltd.
13F holders, Q1 2024 (March 31)8holders
1famous investor
$2.22avg. 13F price*
At the end of Q1 2024, 8 institutions reported holding Can Fite Biofarma Ltd. in their 13F filings. The largest holders were Armistice Capital, LLC ($850K), Morgan Stanley ($124K) and Rhumbline Advisers ($41K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Can Fite Biofarma Ltd.
- CUSIP
- 13471N300
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $36K |
| Exits | 3 | $45K |
Ownership 8 holders
| Armistice Capital, LLC | 0.02% | Add +148.0% | 382,798 | $850K |
| Morgan Stanley | 0.00% | Add +20.6% | 55,807 | $124K |
| Rhumbline Advisers | 0.00% | No change | 18,482 | $41K |
| Citadel Advisors | 0.00% | New | 14,171 | $31K |
| Fifth Third Bancorp | 0.00% | No change | 3,000 | $7K |
| UBS Group AG | 0.00% | New | 2,172 | $5K |
| National Bank of Canada | 0.00% | No change | 600 | $1K |
| Citigroup Inc. | 0.00% | No change | 553 | $1K |
"% of holder's portfolio" is CAN FITE BIOFARMA LTD's weight in each manager's 13F, not the share of Can Fite Biofarma Ltd. the manager owns.